Principia Biopharma Inc. Common Stock
PRNB
PRNB was delisted on the 25th of September, 2020.
0 hedge funds and large institutions have $0 invested in Principia Biopharma Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.
100% less funds holding
Funds holding: 9 → 0 (-9)
100% less capital invested
Capital invested by funds: $6.05M → $0 (-$6.05M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
-$2.1M |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$1.63M |
| 3 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$790K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$590K |
| 5 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
-$491K |
PRNB Hedge Fund Activity: Q4 2020 in Review
0 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Principia Biopharma Inc. Common Stock (PRNB) for Q4 2020, worth a combined $0 — down 100% from $6.05M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PRNB and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Ohio Public Employees Retirement System (OPERS), exiting entirely with an estimated $2.1M sold.
- 0 institutional investors held Principia Biopharma Inc. Common Stock (PRNB) as of Q4 2020, down from 9 in Q3 2020.
- Funds reported $0 of Principia Biopharma Inc. Common Stock stock for Q4 2020, down 100% quarter-over-quarter.
- 0 funds opened new Principia Biopharma Inc. Common Stock positions in Q4 2020 and 9 closed out, a net change of -9 holders.
- The largest Principia Biopharma Inc. Common Stock seller in Q4 2020 was Ohio Public Employees Retirement System (OPERS), an estimated $2.1M sold.
Based on aggregated 13F filings for Q4 2020.